0.39
price up icon1.22%   0.0047
after-market Handel nachbörslich: .40 0.01 +2.56%
loading
Schlusskurs vom Vortag:
$0.3853
Offen:
$0.3827
24-Stunden-Volumen:
640.17K
Relative Volume:
0.61
Marktkapitalisierung:
$46.59M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-225.14M
KGV:
-0.199
EPS:
-1.96
Netto-Cashflow:
$-192.27M
1W Leistung:
-6.77%
1M Leistung:
-15.51%
6M Leistung:
-67.23%
1J Leistung:
-92.11%
1-Tages-Spanne:
Value
$0.3546
$0.398
1-Wochen-Bereich:
Value
$0.3546
$0.50
52-Wochen-Spanne:
Value
$0.3546
$5.195

Invivyd Inc Stock (IVVD) Company Profile

Name
Firmenname
Invivyd Inc
Name
Telefon
(781) 819-0080
Name
Adresse
1601 TRAPELO ROAD, WALTHAM
Name
Mitarbeiter
95
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
IVVD's Discussions on Twitter

Vergleichen Sie IVVD mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
IVVD
Invivyd Inc
0.39 46.59M 0 -225.14M -192.27M -1.96
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
438.40 113.67B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
683.08 74.97B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
665.68 40.50B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
277.16 35.95B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
120.88 29.63B 3.30B -501.07M 1.03B -2.1146

Invivyd Inc Stock (IVVD) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-05 Hochstufung Guggenheim Neutral → Buy
2024-03-26 Hochstufung Morgan Stanley Equal-Weight → Overweight
2023-12-19 Hochstufung Morgan Stanley Underweight → Equal-Weight
2023-05-01 Eingeleitet H.C. Wainwright Buy

Invivyd Inc Aktie (IVVD) Neueste Nachrichten

pulisher
11:04 AM

Invivyd Inc (IVVD) Volatility Hits 11.66% – Here Is What You Should Do - Stocks Register

11:04 AM
pulisher
06:16 AM

We Might See A Profit From Invivyd, Inc. (NASDAQ:IVVD) Soon - Yahoo Finance

06:16 AM
pulisher
04:24 AM

Invivyd seeks FDA nod for COVID-19 treatment in immunocompromised - MSN

04:24 AM
pulisher
Jan 28, 2025

Invivyd’s (IVVD) Buy Rating Reaffirmed at D. Boral Capital - Defense World

Jan 28, 2025
pulisher
Jan 27, 2025

Invivyd's (IVVD) Buy Rating Reiterated at D. Boral Capital - MarketBeat

Jan 27, 2025
pulisher
Jan 27, 2025

Invivyd Provides Another Positive SARS-CoV-2 Variant Data Analysis to Satisfy U.S. FDA's Gating Request for Completing Its Review of EUA Request for PEMGARDA™ (pemivibart) for the Treatment of Mild-to-Moderate COVID-19 in Certain Immunocompromi - The Manila Times

Jan 27, 2025
pulisher
Jan 24, 2025

Invivyd, Inc. (NASDAQ:IVVD) Shares Bought by Barclays PLC - Defense World

Jan 24, 2025
pulisher
Jan 21, 2025

Invivyd, Inc. (NASDAQ:IVVD) Sees Large Increase in Short Interest - Defense World

Jan 21, 2025
pulisher
Jan 14, 2025

Invivyd (NASDAQ:IVVD) vs. iTeos Therapeutics (NASDAQ:ITOS) Head-To-Head Comparison - Defense World

Jan 14, 2025
pulisher
Jan 12, 2025

D. Boral Capital Reiterates Buy Rating for Invivyd (NASDAQ:IVVD) - Defense World

Jan 12, 2025
pulisher
Jan 10, 2025

What's Going On With COVID-19 Antibody Developer Invivyd Stock On Friday? - Yahoo Finance

Jan 10, 2025
pulisher
Jan 10, 2025

Invivyd (NASDAQ:IVVD) Receives "Buy" Rating from D. Boral Capital - MarketBeat

Jan 10, 2025
pulisher
Jan 10, 2025

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC - The Manila Times

Jan 10, 2025
pulisher
Jan 10, 2025

Invivyd's PEMGARDA Shows Powerful Defense Against Dominant COVID Variant XEC in Latest Data - StockTitan

Jan 10, 2025
pulisher
Jan 09, 2025

Barclays PLC Raises Stake in Invivyd, Inc. (NASDAQ:IVVD) - Defense World

Jan 09, 2025
pulisher
Jan 07, 2025

Why Invivyd, Inc. (IVVD) Is Among the Best Penny Stocks to Invest In According to Media? - Yahoo Finance

Jan 07, 2025
pulisher
Jan 06, 2025

12 Best Penny Stocks to Invest in According to the Media - Insider Monkey

Jan 06, 2025
pulisher
Jan 03, 2025

State Street Corp Increases Position in Invivyd, Inc. (NASDAQ:IVVD) - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Invivyd Inc (NASDAQ: IVVD): A Blank Check? - Stocks Register

Jan 02, 2025
pulisher
Jan 01, 2025

Invivyd director Terrance McGuire sells stock worth $131,528 By Investing.com - Investing.com Nigeria

Jan 01, 2025
pulisher
Dec 31, 2024

Insider Selling: Invivyd, Inc. (NASDAQ:IVVD) Director Sells 86,545 Shares of Stock - MarketBeat

Dec 31, 2024
pulisher
Dec 31, 2024

Invivyd director Terrance McGuire sells stock worth $131,528 - Investing.com India

Dec 31, 2024
pulisher
Dec 29, 2024

Invivyd faces Nasdaq delisting over share price rule By Investing.com - Investing.com Nigeria

Dec 29, 2024
pulisher
Dec 29, 2024

Invivyd faces Nasdaq delisting over share price rule - Investing.com

Dec 29, 2024
pulisher
Dec 26, 2024

Terrance Mcguire Sells 119,805 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Terrance Mcguire Sells 83,817 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Terrance Mcguire Sells 75,776 Shares of Invivyd, Inc. (NASDAQ:IVVD) Stock - MarketBeat

Dec 26, 2024
pulisher
Dec 26, 2024

Invivyd director Terrance McGuire sells $164,867 in stock By Investing.com - Investing.com Nigeria

Dec 26, 2024
pulisher
Dec 26, 2024

Invivyd director Terrance McGuire sells $164,867 in stock - Investing.com India

Dec 26, 2024
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Sells 289,312 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Insider Selling: Invivyd, Inc. (NASDAQ:IVVD) Director Sells 74,764 Shares of Stock - MarketBeat

Dec 19, 2024
pulisher
Dec 19, 2024

Invivyd director Terrance McGuire sells shares worth $147,795 By Investing.com - Investing.com South Africa

Dec 19, 2024
pulisher
Dec 19, 2024

Invivyd director Terrance McGuire sells shares worth $147,795 - Investing.com

Dec 19, 2024
pulisher
Dec 16, 2024

Invivyd, Inc. (NASDAQ:IVVD) Director Sells $30,718.73 in Stock - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Invivyd director Terrance McGuire sells $103,384 in stock - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

Invivyd director Terrance McGuire sells $103,384 in stock By Investing.com - Investing.com South Africa

Dec 16, 2024
pulisher
Dec 13, 2024

Adagio Therapeutics Stock Hits 52-Week Low at $0.57 Amid Challenges - Investing.com

Dec 13, 2024
pulisher
Dec 13, 2024

Fmr LLC Sells 1,046,775 Shares of Invivyd, Inc. (NASDAQ:IVVD) - Defense World

Dec 13, 2024
pulisher
Dec 13, 2024

Fmr LLC Decreases Stock Holdings in Invivyd, Inc. (NASDAQ:IVVD) - MarketBeat

Dec 13, 2024
pulisher
Dec 02, 2024

Invivyd announces board member resignation By Investing.com - Investing.com South Africa

Dec 02, 2024
pulisher
Dec 02, 2024

Invivyd announces board member resignation - Investing.com

Dec 02, 2024
pulisher
Nov 29, 2024

Analysts Provide An Important Insights On Invivyd Inc (IVVD) - Stocks Register

Nov 29, 2024
pulisher
Nov 25, 2024

Invivyd's (IVVD) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat

Nov 25, 2024
pulisher
Nov 24, 2024

HC Wainwright Cuts Invivyd (NASDAQ:IVVD) Price Target to $10.00 - Defense World

Nov 24, 2024
pulisher
Nov 23, 2024

FY2024 Earnings Forecast for Invivyd Issued By HC Wainwright - Defense World

Nov 23, 2024

Finanzdaten der Invivyd Inc-Aktie (IVVD)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Invivyd Inc-Aktie (IVVD) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
MCGUIRE TERRANCE
Director
Dec 27 '24
Sale
0.52
83,744
43,647
3,256,776
MCGUIRE TERRANCE
Director
Dec 30 '24
Sale
0.48
86,545
41,784
3,170,231
MCGUIRE TERRANCE
Director
Dec 20 '24
Sale
0.42
119,805
50,725
3,568,274
MCGUIRE TERRANCE
Director
Dec 26 '24
Sale
0.54
83,817
45,563
3,340,520
MCGUIRE TERRANCE
Director
Dec 24 '24
Sale
0.51
68,161
34,503
3,424,337
MCGUIRE TERRANCE
Director
Dec 23 '24
Sale
0.45
75,776
34,076
3,492,498
$352.30
price down icon 5.49%
$41.04
price up icon 0.79%
$22.36
price up icon 3.33%
$5.41
price up icon 3.84%
biotechnology ONC
$226.89
price up icon 0.08%
$120.88
price down icon 0.23%
Kapitalisierung:     |  Volumen (24h):